Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In the world economic growth, the Insulin Glargine industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Insulin Glargine market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Insulin Glargine market size will be further expanded, we expect that by 2024, The market size of the Insulin Glargine will reach XXX million $.
Insulin glargine acts rapidly in the treatment and management of hypoglycemia in patients having either type 1 or type 2 diabetes mellitus. This therapeutic action covers all the signs, mechanisms of action, side effects, precautions, monitoring, and toxicities of insulin glargine which are relevant to medical practitioners in diabetes care. Insulin glargine is also utilized in the treatment and management of obesity in patients with either type I or type II diabetes. The objective of this medication is to suppress the synthesis of glucose in the liver, in patients taking insulin glargine, insulin will be required more to metabolize fats and reduce energy intake.
Insulin glargine is available over the counter in various forms such as injections, tablets, capsules, and injectables. The method of administration usually includes the use of insulin glargine injection under sterile conditions
The growing prevalence of diabetes is propelling the growth of the insulin glargine market. It is man-made insulin and is used to reduce the sugar level from the blood. Increasing preferences for insulin glargine as it is long-acting basal insulin and is beneficial in controlling the blood sugar level. According to the World Health Organization, in 2019, an estimated 1.5 million deaths were directly caused by diabetes. Growing remunerate policies and advancement in the technology of insulin delivery devices is again projected to foster the growth of the market. For instance, in August 2020, Biocon Biologics and Mylan announced the US launch of Semglee™ (insulin glargine injection) in a vial and pre-filled pen presentations, approved to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes.
North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of diabetes in the region. According to the Centers for Disease Control and Prevention, in 2018, 34.2 million Americans—just over 1 in 10—have diabetes. 88 million American adults—approximately 1 in 3—have prediabetes. 34.1 million adults aged 18 years or older—or 13.0% of all US adults—had diabetes.
Key Developments:
- In August 2020, Mylan N.V. and Biocon Biologics India Ltd., a subsidiary of Biocon Ltd. announced the U.S. launch of Semglee™ (insulin glargine injection) in a vial and pre-filled pen presentations, approved to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes
- In July 2017, Merck known as MSD outside of the United States and Canada announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for LUSDUNA™ Nexvue™ (insulin glargine injection) 100 units/mL, a follow-on biologic1 basal insulin in a pre-filled dosing device. LUSDUNA Nexvue is being developed by Merck with funding from Samsung Bioepis
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
Sanofi-Aventis
Ganlee
Biocon
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7):
Product Type Segmentation
Single Dose Vial
Pre-filled Syringe
Industry Segmentation
Treat type2 diabetes
Treat type1 diabetes
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Table of Contents
Section 1 Insulin Glargine Product Definition
Section 2 Global Insulin Glargine Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Insulin Glargine Shipments
2.2 Global Manufacturer Insulin Glargine Business Revenue
2.3 Global Insulin Glargine Market Overview
Section 3 Manufacturer Insulin Glargine Business Introduction
3.1 Sanofi-Aventis Insulin Glargine Business Introduction
3.1.1 Sanofi-Aventis Insulin Glargine Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 Sanofi-Aventis Insulin Glargine Business Distribution by Region
3.1.3 Sanofi-Aventis Interview Record
3.1.4 Sanofi-Aventis Insulin Glargine Business Profile
3.1.5 Sanofi-Aventis Insulin Glargine Product Specification
3.2 Ganlee Insulin Glargine Business Introduction
3.2.1 Ganlee Insulin Glargine Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 Ganlee Insulin Glargine Business Distribution by Region
3.2.3 Interview Record
3.2.4 Ganlee Insulin Glargine Business Overview
3.2.5 Ganlee Insulin Glargine Product Specification
3.3 Biocon Insulin Glargine Business Introduction
3.3.1 Biocon Insulin Glargine Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 Biocon Insulin Glargine Business Distribution by Region
3.3.3 Interview Record
3.3.4 Biocon Insulin Glargine Business Overview
3.3.5 Biocon Insulin Glargine Product Specification
…
Section 4 Global Insulin Glargine Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Insulin Glargine Market Size and Price Analysis 2014-2019
4.1.2 Canada Insulin Glargine Market Size and Price Analysis 2014-2019
4.2 South America Country
4.2.1 South America Insulin Glargine Market Size and Price Analysis 2014-2019
4.3 Asia Country
4.3.1 China Insulin Glargine Market Size and Price Analysis 2014-2019
4.3.2 Japan Insulin Glargine Market Size and Price Analysis 2014-2019
4.3.3 India Insulin Glargine Market Size and Price Analysis 2014-2019
4.3.4 Korea Insulin Glargine Market Size and Price Analysis 2014-2019
4.4 Europe Country
4.4.1 Germany Insulin Glargine Market Size and Price Analysis 2014-2019
4.4.2 UK Insulin Glargine Market Size and Price Analysis 2014-2019
4.4.3 France Insulin Glargine Market Size and Price Analysis 2014-2019
4.4.4 Italy Insulin Glargine Market Size and Price Analysis 2014-2019
4.4.5 Europe Insulin Glargine Market Size and Price Analysis 2014-2019
4.5 Other Country and Region
4.5.1 Middle East Insulin Glargine Market Size and Price Analysis 2014-2019
4.5.2 Africa Insulin Glargine Market Size and Price Analysis 2014-2019
4.5.3 GCC Insulin Glargine Market Size and Price Analysis 2014-2019
4.6 Global Insulin Glargine Market Segmentation (Region Level) Analysis 2014-2019
4.7 Global Insulin Glargine Market Segmentation (Region Level) Analysis
Section 5 Global Insulin Glargine Market Segmentation (Product Type Level)
5.1 Global Insulin Glargine Market Segmentation (Product Type Level) Market Size 2014-2019
5.2 Different Insulin Glargine Product Type Price 2014-2019
5.3 Global Insulin Glargine Market Segmentation (Product Type Level) Analysis
Section 6 Global Insulin Glargine Market Segmentation (Industry Level)
6.1 Global Insulin Glargine Market Segmentation (Industry Level) Market Size 2014-2019
6.2 Different Industry Price 2014-2019
6.3 Global Insulin Glargine Market Segmentation (Industry Level) Analysis
Section 7 Global Insulin Glargine Market Segmentation (Channel Level)
7.1 Global Insulin Glargine Market Segmentation (Channel Level) Sales Volume and Share 2014-2019
7.2 Global Insulin Glargine Market Segmentation (Channel Level) Analysis
Section 8 Insulin Glargine Market Forecast 2019-2024
8.1 Insulin Glargine Segmentation Market Forecast (Region Level)
8.2 Insulin Glargine Segmentation Market Forecast (Product Type Level)
8.3 Insulin Glargine Segmentation Market Forecast (Industry Level)
8.4 Insulin Glargine Segmentation Market Forecast (Channel Level)
Section 9 Insulin Glargine Segmentation Product Type
9.1 Single Dose Vial Product Introduction
9.2 Pre-filled Syringe Product Introduction
Section 10 Insulin Glargine Segmentation Industry
10.1 Treat type2 diabetes Clients
10.2 Treat type1 diabetes Clients
Section 11 Insulin Glargine Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Insulin Glargine Product Picture from Sanofi-Aventis
Chart 2014-2019 Global Manufacturer Insulin Glargine Shipments (Units)
Chart 2014-2019 Global Manufacturer Insulin Glargine Shipments Share
Chart 2014-2019 Global Manufacturer Insulin Glargine Business Revenue (Million USD)
Chart 2014-2019 Global Manufacturer Insulin Glargine Business Revenue Share
Chart Sanofi-Aventis Insulin Glargine Shipments, Price, Revenue and Gross profit 2014-2019
Chart Sanofi-Aventis Insulin Glargine Business Distribution
Chart Sanofi-Aventis Interview Record (Partly)
Figure Sanofi-Aventis Insulin Glargine Product Picture
Chart Sanofi-Aventis Insulin Glargine Business Profile
Table Sanofi-Aventis Insulin Glargine Product Specification
Chart Ganlee Insulin Glargine Shipments, Price, Revenue and Gross profit 2014-2019
Chart Ganlee Insulin Glargine Business Distribution
Chart Ganlee Interview Record (Partly)
Figure Ganlee Insulin Glargine Product Picture
Chart Ganlee Insulin Glargine Business Overview
Table Ganlee Insulin Glargine Product Specification
Chart Biocon Insulin Glargine Shipments, Price, Revenue and Gross profit 2014-2019
Chart Biocon Insulin Glargine Business Distribution
Chart Biocon Interview Record (Partly)
Figure Biocon Insulin Glargine Product Picture
Chart Biocon Insulin Glargine Business Overview
Table Biocon Insulin Glargine Product Specification
…
Chart United States Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart United States Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart Canada Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Canada Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart South America Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart South America Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart China Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart China Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart Japan Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Japan Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart India Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart India Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart Korea Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Korea Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart Germany Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Germany Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart UK Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart UK Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart France Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart France Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart Italy Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Italy Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart Europe Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Europe Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart Middle East Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Middle East Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart Africa Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Africa Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart GCC Insulin Glargine Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart GCC Insulin Glargine Sales Price ($/Unit) 2014-2019
Chart Global Insulin Glargine Market Segmentation (Region Level) Sales Volume 2014-2019
Chart Global Insulin Glargine Market Segmentation (Region Level) Market size 2014-2019
Chart Insulin Glargine Market Segmentation (Product Type Level) Volume (Units) 2014-2019
Chart Insulin Glargine Market Segmentation (Product Type Level) Market Size (Million $) 2014-2019
Chart Different Insulin Glargine Product Type Price ($/Unit) 2014-2019
Chart Insulin Glargine Market Segmentation (Industry Level) Market Size (Volume) 2014-2019
Chart Insulin Glargine Market Segmentation (Industry Level) Market Size (Share) 2014-2019
Chart Insulin Glargine Market Segmentation (Industry Level) Market Size (Value) 2014-2019
Chart Global Insulin Glargine Market Segmentation (Channel Level) Sales Volume (Units) 2014-2019
Chart Global Insulin Glargine Market Segmentation (Channel Level) Share 2014-2019
Chart Insulin Glargine Segmentation Market Forecast (Region Level) 2019-2024
Chart Insulin Glargine Segmentation Market Forecast (Product Type Level) 2019-2024
Chart Insulin Glargine Segmentation Market Forecast (Industry Level) 2019-2024
Chart Insulin Glargine Segmentation Market Forecast (Channel Level) 2019-2024
Chart Single Dose Vial Product Figure
Chart Single Dose Vial Product Advantage and Disadvantage Comparison
Chart Pre-filled Syringe Product Figure
Chart Pre-filled Syringe Product Advantage and Disadvantage Comparison
Chart Treat type2 diabetes Clients
Chart Treat type1 diabetes Clients
